Eocene Ltd. (EOCN) vs Nexalin Technology, Inc. (NXL)
A side-by-side comparison of Eocene Ltd. and Nexalin Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EOCN
Eocene Ltd.
$3.43HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
NXL
Nexalin Technology, Inc.
$4.81HealthcareDelayed quote: Oct 6, 2026, 2:47 PM EDT
Total return — EOCN vs NXL
growth of $100 · dividends reinvested · last 1yEOCN -15.9% (-15.9%/yr)NXL -48.3% (-48.3%/yr)EOCN compounded faster over this window
EOCN NXL
Metrics side by side
Total return (annualized)
| Metric | EOCN | NXL |
|---|---|---|
| Total return (1Y) | N/A | -79.96% |
| Total return CAGR (3Y) | N/A | -22.57% |
EOCN is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.